Similar improvements were observed with both dosing regimens and in patients with or without prior anti-TNF exposure. Correlations were observed between improvements in PROs and DAS28 (data not shown). ConClusions: Improvements observed to Wk24 in generic and diseasespecific PROs were sustained to Wk96 of the RAPID-PsA trial for both CZP dosing regimens.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.